Insecticides India Ltd Q2 FY2026 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/246ghyp4pr5ywqwzp1f4u3nu.pdf

Key Takeaways


The Quarter’s Damage: Weather, Returns, and Flat Volumes

Rajesh Aggarwal: “When the time gets tough, the tough gets going. At Insecticides, we are not just building products, we are building trust, strengthening farmer prosperity and shaping the future of Indian agriculture.”

Portfolio Strategy: The Maharatna Shift Is Working, Even Now

Rajesh Aggarwal: “In the past, whenever I used to launch an off-patented molecule, I used to get the advantage of 2-3 years without competition. Nowadays, competition comes in 6 months.”

Inventory: The Number That Worries

Rajesh Aggarwal: “So, yes, we have suffered on the inventory path which will correct in the time to come forward.”

Field Force, Costs, and the Bet That Didn’t Pay Off

Rajesh Aggarwal: “We are trying. This quarter, we have suffered. But yes, if we look at 1 or 2 or 3 years, then I can say that we are back on our 13% profit trajectory and we’ll take off from here.”

New Launches, Partnerships, and the Manufacturing Build-Out

Rajesh Aggarwal: “So, with so much activities around, and also we are in talks with many large companies of the world to do some CRAM activities or some other activities together. So, we thought that this is the right time to engage a professional who can handle these activities well and who has got a good experience.”

H2 Outlook: Rabi, Exports, and the Recovery Bet

Rajesh Aggarwal: “When something comes as a disaster, it also has positive side. So, the extended rainfall has now given a good opportunity for the Rabi season or the second season because there is a lot of moisture available in soil…”

Guidance & Commitments

CommitmentSpecificsTimeline
Profit trajectoryReturn to 13% profit trajectory and grow continuously from hereOver the next 1–3 years
Focus Maharatna own-technicals shareCross 70% (from current 65%)Next 2–3 years
Export revenueTouch ₹150 crThis fiscal year
Kaeros brand salesCross ₹100 crThis fiscal year (trial/seeding year)
New AI launches3–4 new AIs at least every year, some generic and some specialtyOngoing, annually
New product margin threshold35% plus to qualify for Maharatna segmentOngoing, per launch
H2 performanceImprove performance in both Q3 and Q4H2 FY26

Key Metrics

MetricQ2 FY26
Revenue from operations₹638 cr, +2% YoY
Gross profit₹220 cr, +11% YoY
EBITDA₹89 cr, flat YoY
PAT₹59 cr, -3% YoY
H1 EBITDA margin13%
B2C premium vs generic mix65% premium, 35% generic, vs 67%/33% in FY25
Segment mix: B2C / B2B / Exports77% / 19% / 4%, vs 84%/14%/2% in Q2 FY25
Sales returns~₹150 cr, vs ~₹100 cr in Q2 FY25, up 50%
InventoryCrossed ₹700 cr mid-year; may rise to ₹800 cr for new season purchases
Crop advisors (CAs) deployed~1,200 at quarter-end, peaked at ~1,500 during season
Farmer outreachOver 9,000 farmer meetings, over 5,000 demonstrations, reaching over 100,000 farmers in H1
Kaeros PBT (H1)~₹7 cr
Kaeros gross sales (H1)~₹70 cr
H1 revenue growth~4%
Export full-year target₹150 cr, confident to achieve this year